Immune Checkpoint Inhibitors May Be Associated with High Activity in MSI-H Cancers
Patients with pretreated microsatellite instability-high cancers treated with immune checkpoint inhibitors were found to have high activity, independent of tumor type and drug used.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
More News: Cancer | Cancer & Oncology